HEATHER TYNDALL: Open Payments
NPI 1740361369 · KINSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 63 payments from 15 companies in 2025. Trend: 2023 $2,058 · 2024 $1,689 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $197 |
| Novo Nordisk Inc | 13 | $187 |
| Novartis Pharmaceuticals Corporation | 7 | $144 |
| Lilly USA, LLC | 6 | $111 |
| ABBVIE INC. | 4 | $78 |
| PFIZER INC. | 4 | $65 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Viatris Specialty LLC | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: LEQVIO, OTEZLA, Wegovy, MOUNJARO, EVENITY, UBRELVY, TRELEGY ELLIPTA, YUPELRI.
Industry payments across NC — which companies pay providers there.
